AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26224692
Drug: Culture-directed antibiotic
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culture-directed antibiotic therapy for 2 weeks
Trial: 23650968
Drug: Intranasal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal fentanyl spray (INFS)
Trial: 14611914
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy after complete resection
Trial: 14611914
Drug: Postoperative treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative treatments (chemotherapy, radiotherapy or both)
Trial: 1636624
Drug: Glyburide with
RxNorm normalized name: Glyburide
DrugBank: Glyburide (DB01016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide with fish oil (8 g/d)
Trial: 2936285
Drug: 0.10 mg
RxNorm normalized name: povidone-iodine 0.10 mg in 1 mL TOPICAL SOLUTION [Povidone Iodine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.10 mg . kg‐1 atracurium dibesylate
Trial: 2936285
Drug: 0.15 mg
RxNorm normalized name: iodine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg . kg‐1 atracurium dibesylate
Trial: 29557754
Drug: AC+AN+HL ointment
RxNorm normalized name: Aldex AN
DrugBank: Doxylamine (DB00366)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AC+AN+HL ointment mixture (Group A, N=21)
Trial: 29557754
Drug: AC ointment
RxNorm normalized name: Halonate PAC Ointment Pack
DrugBank: Actinium (DB12860)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AC ointment alone (Group B, N=20)
Trial: 15960427
Drug: Control NT
RxNorm normalized name: NT-219
DrugBank: NT-219 (DB17490)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control NT - no immunostimulating treatment.
Trial: 10515817
Drug: Pneumococcal conjugate
RxNorm normalized name: pneumococcal conjugate PCV 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal conjugate vaccines (3 experimental vaccines containing 6B and 19F)
Trial: 10515817
Drug: Pneumococcal conjugate
RxNorm normalized name: pneumococcal conjugate PCV 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal conjugate vaccines (2 experimental vaccines)
Trial: 10515817
Drug: Pneumococcal conjugate
RxNorm normalized name: pneumococcal conjugate PCV 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal conjugate vaccines (1 experimental vaccine)
Trial: 26277887
Drug: pioglitazone 15
RxNorm normalized name: pioglitazone 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pioglitazone 15 mg once daily
Trial: 26277887
Drug: alogliptin 25
RxNorm normalized name: alogliptin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alogliptin 25 mg once daily (control)
Trial: 21775563
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2.7 g long-chain n-3 fatty acids daily during the third trimester)
Trial: 19957549
Drug: Goserelin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin with 1/2 piece of estradiol patch weekly and 6 mg oral medroxyprogesterone acetate daily for 12 weeks (Group B)
Trial: 19957549
Drug: Goserelin 3.6
RxNorm normalized name: goserelin 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 3.6 mg once every 4 weeks for 12 weeks (Group A)
Trial: 15386934
Drug: G‐Hesperidin at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐Hesperidin at 100 or 500 mg/d for 6 weeks
Trial: 11496020
Drug: Fluoxetine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (6 weeks open-label treatment followed by 6 weeks double-blind treatment)
Trial: 11496020
Drug: Placebo (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (6 weeks double-blind treatment)
Trial: 2205182
Drug: 0.5% topical
RxNorm normalized name: Carac 0.5% Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% topical apraclonidine hydrochloride
Trial: 2205182
Drug: 0.25% topical
RxNorm normalized name: Remyda, 0.25% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% topical apraclonidine hydrochloride
Trial: 71971
Drug: Flurbiprofen 150
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 150 mg twice daily (morning and evening) plus placebo at mid-day
Trial: 71971
Drug: Flurbiprofen 100
RxNorm normalized name: flurbiprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 100 mg three times daily
Trial: 71971
Drug: Flurbiprofen 150
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 150 mg twice daily
Trial: 27712924
Drug: Testosterone administration
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone administration for 48h
Trial: 7645530
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg 3 times daily)
Trial: 7710444
Drug: 0.5-20 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5-20 mg intravenous pancopride
Trial: 7710444
Drug: 5-40 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-40 mg oral solution of pancopride
Trial: 7710444
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg intravenous infusion, oral tablet and oral solution
Trial: 7008978
Drug: Topical benzydamine
RxNorm normalized name: benzydamine Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical benzydamine (10/00)
Trial: 23327032
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg hyperbaric bupivacaine 0.5%
Trial: 23327032
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg hyperbaric bupivacaine 0.5%
Trial: 10442363
Drug: Adjuvant UFT
RxNorm normalized name: UFT
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant UFT (400 mg/day for 12 months)
Trial: 8578802
Drug: Diphtheria/Tetanus (DT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria/Tetanus (DT) vaccine
Trial: 2190540
Drug: Oral low
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral low dose cyclophosphamide
Trial: 19201289
Drug: Oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral placebo treatment
Trial: 2190540
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose cyclophosphamide
Trial: 30640148
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of BCTs (COMBO)
Trial: 23877691
Drug: GS-5885 1
RxNorm normalized name: GS 9137
DrugBank: Elvitegravir (DB09101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: GS-5885 1 mg once daily
Trial: 23877691
Drug: GS-5885 ≥3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GS-5885 ≥3 mg once daily
Trial: 23877691
Drug: GS-5885 30
RxNorm normalized name: GS 9137
DrugBank: Elvitegravir (DB09101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: GS-5885 30 mg and 90 mg once daily
Trial: 20309694
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (CyP) only
Trial: 16464962
Drug: Combined use
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined use of paracetamol and ibuprofen
Trial: 12957421
Drug: Glucose-insulin-potassium (GIK)
RxNorm normalized name: glucose / potassium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-insulin-potassium (GIK) infusion for 8 to 12 hours
Trial: 8891888
Drug: Isocaloric, reduced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isocaloric, reduced fat (< 30%) low‐cholesterol diet with pravastatin (40 mg/day)
Trial: 28816281
Drug: Intravenous flurbiprofen
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous flurbiprofen axetil (1 mg/kg) 1 hour before the procedure
Trial: 28816281
Drug: Intrarectal 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrarectal 5% lidocaine gel (60 mg) 5 minutes before the procedure
Trial: 28816281
Drug: Intrarectal 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrarectal 5% lidocaine gel (60 mg) 5 minutes before the procedure and intravenous flurbiprofen axetil (1 mg/kg) 1 hour before the procedure
Trial: 23065047
Drug: Herbal medicine
RxNorm normalized name: Herbal medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal medicine
Trial: 29883936
Drug: Psychotropic medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotropic medications
Trial: 23752495
Drug: Energy-maintenance diet
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy-maintenance diet (27 g NSP and 5 g RS)
Trial: 16126804
Drug: Intramuscular gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular gentamicin 5 mg/kg/day once-daily (OD)
Trial: 16126804
Drug: Intramuscular gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular gentamicin 5 mg/kg/day thrice-daily (TD)
Trial: 15071015
Drug: Structured treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured treatment interruptions (STIs)
Trial: 15071015
Drug: No structured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No structured treatment interruptions (Control)
Trial: 9564977
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 336 microg/day by metered dose inhaler (MDI)
Trial: 8044782
Drug: Irinotecan (CPT‐11)
DrugBank: Irinotecan (DB00762)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Irinotecan (CPT‐11) administered at dose levels ranging from 50 to 145 mg/m2 (30‐90 min i.v. infusion)
Trial: 3051962
Drug: Golytely-RSS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golytely-RSS plus oral bisacodyl
Trial: 24788581
Drug: Multidimensional Stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidimensional Stimulation group Therapy (MST)
Trial: 17062365
Drug: FGF 2
RxNorm normalized name: FGF 2
DrugBank: Basic Fibroblast Growth Factor (DB14131)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FGF 2 L/min with 1% isoflurane
Trial: 17062365
Drug: FGF 3
RxNorm normalized name: Fibroblast Growth Factor 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FGF 3 L/min with 2% isoflurane
Trial: 373792
Drug: Loestrin-20 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loestrin-20 (20 microgram ethinyl oestradiol and 1 mg norethisterone acetate)
Trial: 6365466
Drug: Piretanide 6
RxNorm normalized name: piretanide 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide 6 mg per day
Trial: 6365466
Drug: Piretanide 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide 12 mg per day
Trial: 29158143
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg Tobrate™
Trial: 24419562
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea (700 ml/day for 14 days)
Trial: 22748970
Drug: Rabeprazole granules
RxNorm normalized name: rabeprazole Granule Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole granules mixed with soft food or infant formula (10 mg)
Trial: 22748970
Drug: Rabeprazole suspension
DrugBank: Rabeprazole (DB01129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rabeprazole suspension with inactive vehicle granules (reference)
Trial: 22748970
Drug: All treatment-emergent
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatment-emergent adverse events (TEAEs)
Trial: 17494097
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone (T) gel (100 mg/d) plus depomedroxyprogesterone acetate (300 mg intramuscularly every 12 weeks) with GnRH antagonist acyline (300 microg/kg subcutaneously every 2 weeks for 12 weeks)
Trial: 9918907
Drug: Losartan 25
RxNorm normalized name: LOSARTAN 25MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 25 mg orally once daily for 1 week
Trial: 7307428
Drug: Morphine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (10 or 20 mg/70 kg)
Trial: 7213520
Drug: Heroin (3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin (3, 6, 12 mg/70 kg)
Trial: 30885157
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of ivermectin and albendazole
Trial: 30885157
Drug: Albendazole monotherapy
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole monotherapy (control)
Trial: 19309197
Drug: Continuation-phase cognitive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation-phase cognitive therapy (C-CT)
Trial: 20306476
Drug: Oral calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcitriol 0.25 mcg twice daily for 1 week, followed by oral calcitriol 0.50 mcg twice daily for 1 week
Trial: 2099194
Drug: Genivir (DIP-253)
RxNorm normalized name: West Dip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genivir (DIP-253) 1% cream
Trial: 7900617
Drug: Atenolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (200 mg/day)
Trial: 3310569
Drug: Acebutolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (400 mg/day)
Trial: 6117063
Drug: Oxprenolol (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxprenolol (160 mg/day)
Trial: 19395973
Drug: Tramadol alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol alone (1.5 mg kg(‐1))
Trial: 19395973
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tramadol (1 mg kg(‐1)) and paracetamol 1 g
Trial: 17484874
Drug: Telaprevir 450
RxNorm normalized name: Telaprevir
DrugBank: Telaprevir (DB05521)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Telaprevir 450 mg every 8 hours
Trial: 24316262
Drug: Telaprevir 750
RxNorm normalized name: Telaprevir
DrugBank: Telaprevir (DB05521)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Telaprevir 750 mg every 8 hours
Trial: 17484874
Drug: Telaprevir 1250
RxNorm normalized name: Telaprevir
DrugBank: Telaprevir (DB05521)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Telaprevir 1250 mg every 12 hours
Trial: 11642016
Drug: Continuous administration
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous administration of Tazocin (12 g/1.5 g a day)
Trial: 7802464
Drug: 5 days
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 days simultaneously continuous injection of 5-FU with Leucovorin (C)
Trial: 20051692
Drug: 3 million
RxNorm normalized name: INTERFERON GAMMA-1B 3 MILLION UNT/0.5ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 million IU of recombinant interleukin-2 (rIL-2) left in the cysts after transvaginal ultrasound-guided drainage (group II) twice
Trial: 10225069
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion of morphine with lidocaine (0.44‐0.98 mg.kg‐1.h‐1)
Trial: 8519216
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of 0.5 mg captopril (n = 16)
Trial: 3027839
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of itraconazole per day for five days
Trial: 3027837
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of itraconazole per day for five days
Trial: 22459724
Drug: Escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10 mg daily for four weeks
Trial: 21738622
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily for four weeks
Trial: 12507707
Drug: Adenosine infusion
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine infusion (50-500 microg kg(‐1) x min(‐1))
Trial: 12507707
Drug: Remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil infusion (0.05-0.5 microg kg(‐1) x min(‐1))
Trial: 6138072
Drug: Vesparax (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vesparax (150 mg secobarbital, 50 mg brallobarbital, 50 mg hydroxyzine)
Trial: 31618540
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (pravastatin)
Trial: 23438935
Drug: Acetazolamide 250
RxNorm normalized name: acetazolamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide 250 mg bid
Trial: 15277331
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 to 100 mg/d
Trial: 8301727
Drug: Saphenous vein
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saphenous vein patch (VP) closure
Trial: 8301727
Drug: Obligatory vein
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Obligatory vein patch (OVP) closure
Trial: 3291646
Drug: Propofol, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol, 2 mg/kg-propofol infusion, 1-20 mg/min-nitrous oxide, 60-70%
Trial: 3291646
Drug: Thiopental, 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental, 4 mg/kg-isoflurane, 0.2-3%-nitrous oxide, 60-70% (control)
Trial: 25352617
Drug: Eight-week, twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eight-week, twice weekly, 90-minute exercise and education programme
Trial: 23415171
Drug: CRAS patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRAS patients with CHF (after 100% oxygen administration)
Trial: 3516262
Drug: 5-FU i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU i.v. weekly for 12 months
Trial: 29286595
Drug: Galantamine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (8 mg/d) plus standard methadone maintenance treatment (TAU)
Trial: 29286595
Drug: Computerized CBT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerized CBT plus standard methadone treatment (TAU)
Trial: 22930115
Drug: Prasugrel 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 60 mg loading dose / 10 mg maintenance dose
Trial: 22930115
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose clopidogrel 150 mg maintenance dose
Trial: 329712
Drug: Pentobarbital (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentobarbital (50 or 150 mg) or sodium secobarbital (50 or 150 mg) or placebo
Trial: 329712
Drug: Morphine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (5 or 10 mg) or meperidine (50 or 100 mg) or placebo
Trial: 31260793
Drug: Obeticholic acid
RxNorm normalized name: Obeticholic acid
DrugBank: Obeticholic acid (DB05990)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Obeticholic acid (OCA) 25 mg
Trial: 23637733
Drug: 7.5 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 µg H1N1pnd09 antigen with MF59‐adjuvant (Pa7.5 µg)
Trial: 18790032
Drug: Candid V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Candid V gel (marketed clotrimazole gel)
Trial: 7978176
Drug: Neostigmine 0.036
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.036 mg/kg body weight
Trial: 7978176
Drug: Neostigmine administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine administration timing
Trial: 3398555
Drug: Oral dipyridamole
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dipyridamole (19 patients)
Trial: 3398555
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and intravenous dipyridamole
Trial: 23593327
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 400 mg orally thrice daily for 8 weeks
Trial: 26853137
Drug: Stop antihypertensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stop antihypertensive drugs
Trial: 8904857
Drug: Bronchodilator therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilator therapy (albuterol or ipratropium bromide)
Trial: 31144427
Drug: Vildagliptin in
RxNorm normalized name: Product containing vildagliptin in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin in combination with metformin
Trial: 29564872
Drug: 8% omega-ceramides,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream applied twice daily (group A)
Trial: 24798767
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg zinc supplementation for 24 weeks
Trial: 20362710
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of EPA + DHA and 2 g of ALA